MedPath

Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Proclear contact lens
Device: O2Optix contact lens
Device: Clear Care Cleaning and Disinfecting Solution
Device: ReNu MultiPlus Multi-Purpose Solution
Registration Number
NCT00813761
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The purpose of this study is to compare two marketed contact lens care solutions in regards to comfort and ocular health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
473
Inclusion Criteria
  • Be at least 18 years old.
  • Signed Informed Consent and Investigator to record this on Case Report Form (CRF) in appropriate space.
  • Require a visual correction in both eyes (monovision allowed but not monofit).
  • Have a contact lens spherical distance requirement between +6.00D and -9.00D in both eyes.
  • Astigmatism of 1.00D or less in the better eye and 1.50D or less in the other eye.
  • Be correctable to a visual acuity of 20/30 (6/9) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease.
Exclusion Criteria
  • Requires concurrent ocular medication.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Clinically significant corneal edema, corneal vascularisation, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Worn lenses on an extended wear basis in the last 3 months.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
  • Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
  • Abnormal lacrimal secretions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Proclear CL and ReNu MPS with SICSProclear contact lensProclear contact lens and ReNu MultiPlus Multi-Purpose Solution
Proclear CL and ReNu MPS without SICSProclear contact lensProclear contact lens and ReNu MultiPlus Multi-Purpose Solution
Proclear CL and Clear Care LCS without SICSProclear contact lensProclear contact lens and Clear Care lens care solution
Proclear CL and Clear Care LCS without SICSClear Care Cleaning and Disinfecting SolutionProclear contact lens and Clear Care lens care solution
02Optix CL and ReNu MPS with SICSReNu MultiPlus Multi-Purpose SolutionO2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution
02Optix CL and Clear Care LCS with SICSO2Optix contact lensO2Optix contact lens and Clear Care lens care solution subject
02Optix CL and Clear Care LCS with SICSClear Care Cleaning and Disinfecting SolutionO2Optix contact lens and Clear Care lens care solution subject
Proclear CL and Clear Care LCS with SICSProclear contact lensProclear contact lens and Clear Care lens care solution
Proclear CL and Clear Care LCS with SICSClear Care Cleaning and Disinfecting SolutionProclear contact lens and Clear Care lens care solution
02Optix CL and ReNu MPS with SICSO2Optix contact lensO2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution
Proclear CL and ReNu MPS with SICSReNu MultiPlus Multi-Purpose SolutionProclear contact lens and ReNu MultiPlus Multi-Purpose Solution
02Optix CL and ReNu MPS without SICSReNu MultiPlus Multi-Purpose SolutionO2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution
Proclear CL and ReNu MPS without SICSReNu MultiPlus Multi-Purpose SolutionProclear contact lens and ReNu MultiPlus Multi-Purpose Solution
02Optix CL and Clear Care LCS without SICSO2Optix contact lensO2Optix contact lens and Clear Care lens care solution
02Optix CL and ReNu MPS without SICSO2Optix contact lensO2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution
02Optix CL and Clear Care LCS without SICSClear Care Cleaning and Disinfecting SolutionO2Optix contact lens and Clear Care lens care solution
Primary Outcome Measures
NameTimeMethod
Lens Comfort24 weeks

Lens comfort at time of month 6 visit, using a scale of 0 to 10, where 10=excellent.

Average Daily Comfortable Wear Time24 weeks

Average hours per day that contact lens were worn comfortably.

Frequency of Eye Discomfort24 weeks

Subjective measure of typical daily eye discomfort reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Average Daily Wear Time24 weeks

Average hours per day that contact lens were worn.

Frequency of Eye Burning/Stinging24 weeks

Subjective measure of typical daily eye burning and stinging reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Tarsal Roughness24 weeks

The roughness of the inner lining of the eyelids, measured on a 0 to 7 scale. 0=Smooth, 1=Slightly uneven, 2=Uneven surface, 3=Uneven surface with loss of transparency \& superficial vessels, 4=Small papillae, poor transparency, 5=Papillae greater than 0.5mm in size, no transparency, 6=Papillae greater than 0.5mm in size, vessels inside papillae, 7=Large papillae

Average Corneal Fluorescein Type Staining24 weeks

staining measured over five sectors of the cornea and classified as a type of staining on a scale of 0 to 4. 0=None, 1=Micropunctate, 2=Macropunctate, 3=Coalesced Macropunctate, 4=Patch.

Bulbar Redness24 weeks

Redness of the blood vessels in the tissues overlaying the white of the eye, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Upper Tarsal Redness24 weeks

Redness of the blood vessels in the inner lining of the upper eyelid, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Frequency of Daily Lens Dryness24 weeks

Subjective measure of typical daily contact lens dryness reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Frequency of Itching24 weeks

Subjective measure of typical daily eye burning and stinging reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Frequency of Tearing24 weeks

Subjective measure of typical daily tearing related to lens wear reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Average Corneal Fluorescein Staining Area24 weeks

corneal staining measured over 5 areas, averaged, and graded as a single score average on a scale of 0 to 10, 0=0%, 1=10%, 2=20%, 3=30%, 4=40%, 5=50%, 6=60%, 7=70%, 8=80%, 9=90%, 10=100%.

Limbal Redness24 weeks

Redness at the transition zone between the white of the eye and the clear window of the eye, the cornea, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Lower Tarsal Redness24 weeks

Redness of the blood vessels in the inner lining of the lower eyelid, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Secondary Outcome Measures
NameTimeMethod
Intensity of Physiological Outcomes24 weeks

Mean of physiological outcomes for those subjects who are identified as susceptible versus non-susceptible to "Solution Induced Corneal Staining (SICS)". These measures are related to intensity of outcomes, i.e. discomfort, burning, dryness, etc. with lower scores being better on a scale of 1-5.

Wearing Time and Comfortable Wearing Time24 weeks

Mean of physiological outcomes for those subjects who are identified as susceptible versus non-susceptible for "Solution Induced Corneal Staining (SICS)". Average wearing time and average comfortable wearing time.

Physiological Responses24 weeks

Mean of physiological outcomes for those subjects who are identified as susceptible versus non-susceptible for "Solution Induced Corneal Staining (SICS)". Physiological findings are done through a slit lamp examination and are known as biomicroscopy measurements. Measures are given in terms of average score with a minimum of zero and a worse grade the higher the value with a range of 0 to 4, (tarsal roughness is 0-7 scale).

© Copyright 2025. All Rights Reserved by MedPath